Penetration Route of the selective glucocorticoid receptor agonist sa22465 and betamethasone into rabbit meibomian gland based on pharmacokinetics and autoradiography

Asano N., Ueda K., Kawazu K.

2017
Drug Metabolism and Disposition

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Preclinical development

Affiliations

Nara Research and Development Center, Santen Pharmaceutical Co., Ltd., Pharmacology Group, 8916-16, Takayama-cho, Ikoma-city, Nara, 630-0101, Japan

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P, Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

View all Front of the eye (FOTE) publications

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022